Skip to Content
Merck
CN
  • Immunoprecipitation to Determine JAK Kinase Activation in Response to Interleukins in Ovarian Cancer.

Immunoprecipitation to Determine JAK Kinase Activation in Response to Interleukins in Ovarian Cancer.

Methods in molecular medicine (2001-01-01)
T Murata
ABSTRACT

In cytokine receptors, there is no consensus sequence motif for tyrosine and/or serine/threonine kinases in its intracellular domain (1). Cytokine receptors associate with and activate members of the Janus kinase family (JAK), which is phosphorylated following ligand binding (2). The JAK family consists of four kinase members, JAK1, JAK2, JAK3, and Tyk2. Recently, we have shown that in ovarian cancer cell lines, many IL-4 receptors were expressed and IL-4 inhibited the proliferation of ovarian carcinoma cell lines (3). Moreover, IL-4 induced the phosphorylation of JAK1, JAK2, Tyk2, STAT6, and IRS-1 proteins following ligand-receptor interaction (4).

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Albumin from chicken egg white, lyophilized powder, ≥90% (agarose gel electrophoresis)
Sigma-Aldrich
Anti-Phosphotyrosine Antibody, clone 4G10®, Biotin Conjugate, clone 4G10®, Upstate®, from mouse